• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsSelectimmune Pharma AB
    Picture of Selectimmune Pharma AB logo

    SELECT B — Selectimmune Pharma AB Share News

    SEK2.370.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      SEK41.38m
    • Enterprise Value
      SEK35.54m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SELECT B Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SELECT B Dividends
    • Brief: Selectimmune Pharma Says Co's CEO Ann Gidner Will Leave Selectimmune Pharma

      27/03/2022 10:01
    • Brief: Lonza Collaborates With Selectimmune Collaborates To Develop Immunotherapeutic Drug Candidate

      21/06/2021 14:06
    • Brief: Selectimmune Pharma Q2 Pretax Loss Widens To SEK 3.1 Mln

      26/02/2021 08:06
    • Brief: Selectimmune Pharma Q1 Pretax Loss Narrows To SEK 2.2 Million

      11/11/2020 07:37
    • Brief: Selectimmune Pharma Signs Deal On Phase II Study For Infection Treatment

      29/10/2020 08:58
    • Brief: SelectImmune Pharma Announces Patent Granted For IRF7 Inhibitors Case

      16/09/2020 07:35
    • Brief: Selectimmune Q4 Loss After Tax Narrows To SEK 1.1 Million

      27/08/2020 07:38
    • Brief: Selectimmune Pharma Appoints Ann Gidner As New CEO

      16/06/2020 08:38
    • Brief: Selectimmune Pharma Q3 Pretax Loss Widens To SEK 2.4 Mln

      20/05/2020 07:36
    • Brief: Selectimmune Pharma Changes CEO

      27/04/2020 10:52
    • Brief: Selectimmune Pharma: Results From Clinical Study With IL-1 Receptor Inhibitors

      23/04/2020 08:12
    • Brief: Selectimmune: Positive Study Results

      15/04/2020 10:19
    • Brief: Selectimmune Pharma Announces Preliminary Results From New Pre-Clinical Study

      07/10/2019 15:38

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.